This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
5/7/2024
Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies first quarter 2024 earnings call. Please note, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising that your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Corina Calendia, Head of Investor Relations. Please go ahead.
Thank you, Corey, and good afternoon, everyone.
I would like to welcome you to Adaptive Biotechnology's first quarter 2024 earnings conference call. Earlier today, we issued a press release reporting adaptive financial results for the first quarter of 24. The press release is available at www.adaptivebiotech.com. We are conducting a live webcast of these calls and will be referencing to a slide presentation that has been posted to the investor section in our corporate website. During the call, management will make projections and other looking forward statements within the meaning of federal security laws regarding future events and the future financial performance of the company. These statements reflect management's current perspective of the business as of today. Actual results may differ materially from today's forward-looking statements, depending on a number of factors which are set forth in our public silence with the SEC and listed in this presentation. In addition, non-GAAP financial measures will be discussed during the call and will be reconciliated in a non-GAAP-to-GAAP metric that can be found in the earnings release. Joining the call today are Chad Robbins, our CEO and co-founder, and Carl Pisco, our chief financial officer. Additional members from management will be available for Q&A. With that, I'll turn the call over to Chad Robinson. Chad?
You're reading a preview of the ADPT Q1 2024 earnings call.
Free account.
